Skip to content

LIFEMD, INC.: 10-Q filed 2025-11-17

What LIFEMD, INC. reported in its quarterly report filed 2025-11-17 (fiscal Q3 2025): 48 published measures, 174 facts as tagged in accession 0001493152-25-023906.

This filing

Form
10-Q (quarterly report)
Filed
2025-11-17
Fiscal period
fiscal Q3 2025
Accession
0001493152-25-023906 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All LIFEMD, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-3065,983,378USD
At 2024-12-3176,096,297USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-09-3062,615,226USD
At 2024-12-3183,650,417USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-09-301,314,334USD
At 2024-12-31-9,083,214USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-3,806,117USD92
2025-01-01 to 2025-09-30-5,609,559USD273
2025-04-01 to 2025-06-30-1,619,664USD91
2025-01-01 to 2025-06-30-1,803,442USD181
2025-01-01 to 2025-03-31-183,778USD90
2024-01-01 to 2024-12-31-21,409,016USD366
2024-07-01 to 2024-09-30-4,657,922USD92
2024-01-01 to 2024-09-30-16,470,351USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-3011,560,698USD273
2025-01-01 to 2025-06-3011,707,834USD181
2025-01-01 to 2025-03-313,068,387USD90
2024-01-01 to 2024-12-3117,513,190USD366
2024-01-01 to 2024-09-3016,439,889USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2025-01-01 to 2025-09-301,715,214USD273
2024-01-01 to 2024-09-301,265,447USD274

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2025-07-01 to 2025-09-3060,172,470USD92
2025-01-01 to 2025-09-30186,975,039USD273
2025-04-01 to 2025-06-3062,673,395USD91
2025-01-01 to 2025-06-30126,802,569USD181
2025-01-01 to 2025-03-3164,129,174USD90
2024-01-01 to 2024-12-31208,839,282USD366
2024-07-01 to 2024-09-3053,272,294USD92
2024-01-01 to 2024-09-30149,337,063USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-12,618,450USD273
2024-01-01 to 2024-09-30-3,183,770USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-10,161,401USD273
2024-01-01 to 2024-09-30-8,815,591USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-247,790,178USD
At 2024-12-31-239,850,931USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-07-01 to 2025-09-3046,162,625shares92
2025-01-01 to 2025-09-3044,575,553shares273
2024-07-01 to 2024-09-3042,020,965shares92
2024-01-01 to 2024-09-3040,857,344shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-07-01 to 2025-09-3046,162,625shares92
2025-01-01 to 2025-09-3044,575,553shares273
2024-07-01 to 2024-09-3042,020,965shares92
2024-01-01 to 2024-09-3040,857,344shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-0.05USD/shares91
2025-01-01 to 2025-06-30-0.08USD/shares181
2025-01-01 to 2025-03-31-0.02USD/shares90
2024-01-01 to 2024-12-31-0.6USD/shares366
2024-07-01 to 2024-09-30-0.13USD/shares92
2024-01-01 to 2024-09-30-0.46USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-0.05USD/shares91
2025-01-01 to 2025-06-30-0.08USD/shares181
2025-01-01 to 2025-03-31-0.02USD/shares90
2024-01-01 to 2024-12-31-0.6USD/shares366
2024-07-01 to 2024-09-30-0.13USD/shares92
2024-01-01 to 2024-09-30-0.46USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-07-01 to 2025-09-30169,134USD92
2025-01-01 to 2025-09-30169,134USD273
2024-07-01 to 2024-09-30232,523USD92
2024-01-01 to 2024-09-30232,523USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-09-302,584,829USD
At 2024-12-311,479,184USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-09-307,841,178USD273
2024-01-01 to 2024-09-309,129,841USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-1,969,214USD92
2025-01-01 to 2025-09-30-1,446,434USD273
2025-04-01 to 2025-06-30-451,562USD91
2025-01-01 to 2025-06-30522,780USD181
2025-01-01 to 2025-03-31974,342USD90
2024-01-01 to 2024-12-31-18,276,324USD366
2024-07-01 to 2024-09-30-3,996,274USD92
2024-01-01 to 2024-09-30-14,433,048USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-3041,085,605USD
At 2024-12-3152,369,360USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2025-07-01 to 2025-09-30262,456USD92
2025-01-01 to 2025-09-301,551,758USD273
2024-07-01 to 2024-09-30558,597USD92
2024-01-01 to 2024-09-301,567,743USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-3056,663,553USD
At 2024-12-3167,400,168USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-09-3019,554,735USD
At 2024-12-3116,009,484USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-09-301,558,318USD
At 2024-12-312,030,656USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-09-309,244,321USD
At 2024-12-3110,854,084USD
At 2023-12-316,265,762USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2025-07-01 to 2025-09-30270,000USD92

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-07-01 to 2025-09-3054,733,771USD92
2025-01-01 to 2025-09-30164,938,940USD273
2024-01-01 to 2024-12-31203,047,127USD366
2024-07-01 to 2024-09-3052,255,027USD92
2024-01-01 to 2024-09-30149,131,478USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-09-303,432,382USD
At 2024-12-312,797,358USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-3052,764,557USD92
2025-01-01 to 2025-09-30163,492,506USD273
2025-04-01 to 2025-06-3055,242,491USD91
2025-01-01 to 2025-06-30110,727,949USD181
2025-01-01 to 2025-03-3155,485,458USD90
2024-01-01 to 2024-12-31184,770,803USD366
2024-07-01 to 2024-09-3048,258,753USD92
2024-01-01 to 2024-09-30134,698,430USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2025-07-01 to 2025-09-307,407,913USD92
2025-01-01 to 2025-09-3023,482,533USD273
2024-07-01 to 2024-09-305,013,541USD92
2024-01-01 to 2024-09-3014,638,633USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-3046,583,310shares
At 2024-12-3142,190,867shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-09-30248,801,209USD
At 2024-12-31230,508,339USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2025-09-303,368,152USD
At 2025-06-30-4,239,744USD
At 2025-03-31-5,470,088USD
At 2024-12-31-7,554,120USD
At 2024-09-30-5,097,347USD
At 2024-06-30-1,891,625USD
At 2024-03-312,392,950USD
At 2023-12-314,189,049USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-09-305,578,992USD
At 2024-12-316,400,596USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-09-306,525,155USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2025-09-3022,079,805USD
At 2024-12-3122,811,763USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-3,387,521USD92
2025-01-01 to 2025-09-30-4,154,043USD273
2024-01-01 to 2024-12-3120,458,141USD366
2024-07-01 to 2024-09-30-4,554,871USD92
2024-01-01 to 2024-09-30-16,000,791USD274

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-3,556,655USD92
2025-01-01 to 2025-09-30-4,323,177USD273
2025-04-01 to 2025-06-30-1,114,589USD91
2025-01-01 to 2025-06-30-766,522USD181
2025-01-01 to 2025-03-31348,067USD90
2024-01-01 to 2024-12-31-20,860,141USD366
2024-07-01 to 2024-09-30-4,787,394USD92
2024-01-01 to 2024-09-30-16,233,314USD274
2024-04-01 to 2024-06-30-7,534,958USD91
2024-01-01 to 2024-03-31-3,910,962USD91

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-4,582,680USD92
2025-01-01 to 2025-09-30-7,939,247USD273
2025-04-01 to 2025-06-30-2,396,226USD91
2025-01-01 to 2025-06-30-3,356,567USD181
2025-01-01 to 2025-03-31-960,341USD90
2024-01-01 to 2024-12-31-24,515,266USD366
2024-07-01 to 2024-09-30-5,434,485USD92
2024-01-01 to 2024-09-30-18,800,039USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-3016,589,390USD92
2025-01-01 to 2025-09-3051,210,246USD273
2024-01-01 to 2024-12-3171,179,108USD366
2024-07-01 to 2024-09-3018,115,143USD92
2024-01-01 to 2024-09-3051,160,883USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-01-01 to 2025-09-30609,569USD273
2024-01-01 to 2024-09-30321,698USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2025-07-01 to 2025-09-30269,000USD92
2025-01-01 to 2025-09-30775,338USD273
2024-07-01 to 2024-09-30246,000USD92
2024-01-01 to 2024-09-30737,836USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-09-301,461,032USD273
2024-01-01 to 2024-09-301,913,049USD274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2025-01-01 to 2025-09-30482,471USD273
2024-01-01 to 2024-09-30198,176USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2025-07-01 to 2025-09-308,700,000USD92
2025-01-01 to 2025-09-308,721,717USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2025-01-01 to 2025-09-30655,253USD273
2024-01-01 to 2024-09-30615,281USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-1,609,763USD273
2025-01-01 to 2025-06-30-1,533,367USD181
2025-01-01 to 2025-03-31467,855USD90
2024-01-01 to 2024-12-314,588,323USD366
2024-01-01 to 2024-09-305,222,534USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30635,024USD273
2024-01-01 to 2024-09-30-114,489USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-303,545,251USD273
2024-01-01 to 2024-09-304,782,614USD274

Inspect the source

Entity
LIFEMD, INC. / CIK 0000948320
Captured
2026-09-20T05:10:44.536Z
SEC response SHA-256
78c33133d98137bc77be369f3fdf06a230aa44209734e0bf6c96639c34395268

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000948320.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))